Radiofrequency ablation vs. antiarrhythmic drug therapy as first line treatment of symptomatic atrial fibrillation: systematic review and meta-analysis

Three-month lower-dose flecainide after catheter ablation of atrial fibrillation

(2014) M. Hayashi et al.   EUROPACE

The Atrial Fibrillation Ablation Pilot Study: an European Survey on Methodology and results of catheter ablation for atrial fibrillation conducted by the European Heart Rhythm Association

(2014) Elena Arbelo et al.   EUROPEAN HEART JOURNAL

Recurrence of arrhythmia following short-term oral AMIOdarone after CATheter ablation for atrial fibrillation: a double-blind, randomized, placebo-controlled study (AMIO-CAT trial)

(2014) S. Darkner et al.   EUROPEAN HEART JOURNAL

Radiofrequency Ablation vs Antiarrhythmic Drugs as First-Line Treatment of Paroxysmal Atrial Fibrillation (RAAFT-2)

(2014) Carlos A. Morillo et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Association of Atrial Tissue Fibrosis Identified by Delayed Enhancement MRI and Atrial Fibrillation Catheter Ablation

(2014) Nassir F. Marrouche et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

(2014) Craig T. January et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

In-Hospital Complications Associated With Catheter Ablation of Atrial Fibrillation in the United States Between 2000 and 2010

(2013) Abhishek Deshmukh et al.   CIRCULATION

ESC-EURObservational Research Programme: the Atrial Fibrillation Ablation Pilot Study, conducted by the European Heart Rhythm Association

(2012) E. Arbelo et al.   EUROPACE

2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society

(2012) H. Calkins et al.   EUROPACE

2012 focused update of the ESC Guidelines for the management of atrial fibrillation

(2012) et al.   EUROPACE

Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trial

(2012) Paulus Kirchhof et al.   LANCET

Radiofrequency Ablation as Initial Therapy in Paroxysmal Atrial Fibrillation

(2012) Jens Cosedis Nielsen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Long-term effects of catheter ablation for lone atrial fibrillation: Progressive atrial electroanatomic substrate remodeling despite successful ablation

(2011) Andrew W. Teh et al.   HEART RHYTHM

Cardiovascular Outcomes in the AFFIRM Trial (Atrial Fibrillation Follow-Up Investigation of Rhythm Management)

(2011) Sanjeev Saksena et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Dronedarone in High-Risk Permanent Atrial Fibrillation

(2011) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy and safety of catheter ablation versus antiarrhythmic drugs for atrial fibrillation: a meta-analysis of randomized trials

(2010) Carlo Bonanno et al.   Journal of Cardiovascular Medicine

Long-Term Quality of Life After Ablation of Atrial Fibrillation

(2010) Anita Wokhlu et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Antiarrhythmics After Ablation of Atrial Fibrillation (5A Study)

(2009) Jean-François Roux et al.   CIRCULATION

Treatment of Atrial Fibrillation With Antiarrhythmic Drugs or Radiofrequency Ablation

(2009) Hugh Calkins et al.   Circulation-Arrhythmia and Electrophysiology

Pulmonary Vein Isolation for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation

(2009) Jonathan P. Piccini et al.   Circulation-Arrhythmia and Electrophysiology

Updated Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial Fibrillation

(2009) Riccardo Cappato et al.   Circulation-Arrhythmia and Electrophysiology

Antiarrhythmic therapy and risk of death in patients with atrial fibrillation: a nationwide study

(2009) S. S. Andersen et al.   EUROPACE

Early and comprehensive management of atrial fibrillation: Proceedings from the 2nd AFNET/EHRA consensus conference on atrial fibrillation entitled 'research perspectives in atrial fibrillation'

(2009) P. Kirchhof et al.   EUROPACE

Complications of Atrial Fibrillation Ablation in a High-Volume Center in 1,000 Procedures: Still Cause for Concern?

(2009) NIKOLAOS DAGRES et al.   JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY

A Systematic Review of Randomized Trials Comparing Radiofrequency Ablation with Antiarrhythmic Medications in Patients with Atrial Fibrillation

(2008) GIRISH M. NAIR et al.   JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY